Enoximone: Myogen began a placebo-controlled international Phase III trial using low dose enoximone in 1,400 patients with advanced (NYHA Class III or IV) CHF.

Myogen Inc., Denver, Colo. Product: Enoximone Business: Cardiovascular Therapeutic category: Vasodilation, Signal transduction Target: PDE3 Description: Oral phosphodiesterase type III (PDE3) inhibit...